0001140361-23-000826.txt : 20230106 0001140361-23-000826.hdr.sgml : 20230106 20230106165918 ACCESSION NUMBER: 0001140361-23-000826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230106 DATE AS OF CHANGE: 20230106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILL MATTHEW C CENTRAL INDEX KEY: 0001278675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 23515732 MAIL ADDRESS: STREET 1: C/O STRATA SKIN SCIENCES, INC. STREET 2: 5 WALNUT GROVE DRIVE, SUITE 140 CITY: HORSHAM STATE: PA ZIP: 19044 FORMER NAME: FORMER CONFORMED NAME: HILL MATHEW C DATE OF NAME CHANGE: 20040204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml X0306 4 2023-01-05 0001472091 PDS Biotechnology Corp PDSB 0001278675 HILL MATTHEW C C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD, SUITE 300 FLORHAM PARK NJ 07932 true Chief Financial Officer Employee Stock Option (Right to Buy) 11.61 2023-01-05 4 A 0 161200 0 A 2033-01-05 Common Stock 161200 161200 D This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027. /s/ Matthew C. Hill 2023-01-06